Is it safe to breastfeed if you take Valturna? Because no research has been done to see if the two medications in this product pass through human breast milk, the answer is currently unknown. Due to this lack of information, your healthcare provider may recommend other blood pressure medications if you are breastfeeding.
Is Valturna Safe for Breastfeeding Women?
Valturna® (aliskiren and valsartan) is a prescription medication used to treat high blood pressure. It is not clear if this medication is safe for use while breastfeeding. Therefore, you should talk with your healthcare provider before taking Valturna if you are breastfeeding or plan to start.
In April 2012, it was decided that this medication should no longer be available, due to the risks it poses to people with diabetes or with moderate-to-severe kidney problems. Production will officially cease in July 2012.
More Information on Breastfeeding While Taking Valturna
No research has been done to see if either of the two active ingredients in Valturna pass through breast milk in humans, although both medications are known to pass through breast milk in rats. The manufacturer recommends against taking this medication while breastfeeding.
Although there is no evidence that Valturna will cause problems if used during breastfeeding, there is also no evidence to suggest that it can be used safely while breastfeeding. Due to the lack of evidence either way, other blood pressure medications may be preferred for women who are nursing.
Talking With Your Healthcare Provider
You should discuss breastfeeding and Valturna with your healthcare provider. Each woman's situation is different, and you and your healthcare provider understand your situation best. After considering what you want and expect, as well as your current health situation, the two of you can make a shared decision that is right for you.
Written by/reviewed by: Kristi Monson, PharmD;Arthur Schoenstadt, MD
Last reviewed by: KristiMonson, PharmD;
List of references (click here):
Valturna [package insert]. East Hanover, NJ: Novartis Pharmaceuticals Corporation;2011 April.
Food and Drug Administration, Center for Drug Evaluation and Research. FDA drug safety communication: new warning and contraindication for blood pressure medicines containing aliskiren (Tekturna) (4/20/2012). FDA Web site. Available at: http://www.fda.gov/Drugs/DrugSafety/ucm300889.htm. Accessed April 25, 2012.
Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation. 8th ed. Philadelphia (PA): Lippincott Williams & Wilkins;2008.
National Library of Medicine (US). Drugs and Lactation Database (LactMED). NLM Web site. Available at: http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT. Accessed October 7, 2009.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click